RGBP — Regen BioPharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Regen BioPharma, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.008	0	0.727	0.051	0.121
Net Total Accounts Receivable
Net Total Receivables	0.071	0.103	0.219	0.254	0
Prepaid Expenses
Total Current Assets	0.079	0.103	0.994	0.336	0.131
Long Term Investments
Other Long Term Assets
Total Assets	0.099	0.123	1.21	0.559	0.354
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11	7.46	14.7	8.6	5.31
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	11	7.46	14.7	8.6	5.46
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-10.9	-7.33	-13.5	-8.04	-5.1
Total Liabilities & Shareholders' Equity	0.099	0.123	1.21	0.559	0.354
Total Common Shares Outstanding
Total Preferred Shares Outstanding